Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that on January 8, 2009 it entered into a securities purchase agreement with Robert ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE